I agree that this site is using cookies. You can find further informations here.
X
Pawaskar, Dipti
15  results:
OpenAccess-fulltext X
Search for persons X
?
1

Pharmacokinetic/pharmacodynamic modeling for dose selection..:

Pawaskar, Dipti ; Chen, Xi ; Glassman, Fiona...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932701/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
2

A phase I, first‐in‐human, randomized dose‐escalation study..:

McKenzie, Andrew ; Roberts, Anthony ; Malandkar, Sourabh...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932690/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
3

Long-term outcomes with subcutaneous C1-inhibitor replaceme..:

Craig, Timothy ; Zuraw, Bruce ; Longhurst, Hilary...
http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/49199.  , 2019
Link: http://publikationen.ub...
 
?
4

Population pharmacokinetics of subcutaneous C1-inhibitor fo..:

Pawaskar, Dipti ; Tortorici, Michael A ; Zuraw, Bruce...
Clinical and Experimental Allergy--0954-7894--1365-2222 Vol. 48 Issue. 10 pp: 1325-1332.  , 2018
Link: https://doi.org/10.1111/..
 
?
5

Exposure‐Response Model of Subcutaneous C1‐Inhibitor Concen..:

Zhang, Ying ; Tortorici, Michael A ; Pawaskar, Dipti...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869560/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
6

Methods of utilizing baseline values for indirect response ..:

Woo, Sukyung ; Pawaskar, Dipti ; Jusko, William J
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712653.  , 2009
Link: http://www.ncbi.nlm.nih...
 
?
7

Synergistic interactions between sorafenib and everolimus i..:

Pawaskar, Dipti K ; Straubinger, Robert M ; Fetterly, Gerald J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
8

Physiologically based pharmacokinetic models for everolimus..:

Pawaskar, Dipti K ; Straubinger, Robert M ; Fetterly, Gerald J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
9

Interactions of Everolimus and Sorafenib in Pancreatic Canc..:

Pawaskar, Dipti K ; Straubinger, Robert M ; Fetterly, Gerald J..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535103.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
10

Interactions of Everolimus and Sorafenib in Whole Blood Lym..:

Pawaskar, Dipti K ; Straubinger, Robert M ; Fetterly, Gerald J..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726064.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
11

A phase I, first‐in‐human, randomized dose‐escalation study..:

Andrew McKenzie ; Anthony Roberts ; Sourabh Malandkar...
https://doi.org/10.1111/cts.13180.  , 2022
Link: https://doi.org/10.1111/..
 
?
12

Pharmacokinetic/pharmacodynamic modeling for dose selection..:

Dipti Pawaskar ; Xi Chen ; Fiona Glassman...
https://doi.org/10.1111/cts.13192.  , 2022
Link: https://doi.org/10.1111/..
 
?
13

Population pharmacokinetics of subcutaneous C1-inhibitor fo..:

Marc A. Riedl ; Jonathan A. Bernstein ; Paul K. Keith...
url:https://www.openaccessrepository.it/communities/itmirror.  , 2018
Link: https://www.openaccessre..
 
?
14

Abstracts from the 10th C1-inhibitor deficiency workshop:

Alvin H. Schmaier ; Marco Cicardi ; Avner Reshef...
http://link.springer.com/article/10.1186/s13223-017-0198-5.  , 2017
Link: https://doi.org/10.1186/..
 
?
15

An open labeled, randomized, controlled clinical study to e..:

Renuka Munshi ; Dipti Kumbhar ; Pranesh Pawaskar..
http://www.sciencedirect.com/science/article/pii/S0975947622000183.  , 2022
Link: https://doi.org/10.1016/..
 
1-15